BackVanta Bioscience Limited Overview

Vanta Bioscience Limited Total Current Liabilities

Track Vanta Bioscience Limited's total current liabilities ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$118.21M
↓ 55.50% YoYΔ $-147.43M vs prior year quarter

Peer trimmed avg / median

Loading

Vanta Bioscience Limited Total Current Liabilities History

Loading

Vanta Bioscience Limited vs. peers: Total Current Liabilities Comparison

Loading

Vanta Bioscience Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vanta Bioscience Limited (VANTABIO.BO) FAQ

As of the most recent data (March 2026), VANTABIO.BO shows a total current liabilities of $120M. That compares with $270M in the prior-year period — down 55.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VANTABIO.BO's total current liabilities is now $120M (was $270M) — a 55.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vanta Bioscience Limited is outperforming or lagging.

Tracking VANTABIO.BO's total current liabilities over time shows whether Vanta Bioscience Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $120M That compares with $270M in the prior-year period — down 55.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Vanta Bioscience Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $120M) with ownership activity and broader fundamentals.

Vanta Bioscience Limited's total current liabilities is $120M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.